R
Rishi Gupta
Researcher at WellStar Health System
Publications - 243
Citations - 11242
Rishi Gupta is an academic researcher from WellStar Health System. The author has contributed to research in topics: Stroke & Modified Rankin Scale. The author has an hindex of 48, co-authored 215 publications receiving 9059 citations. Previous affiliations of Rishi Gupta include NewYork–Presbyterian Hospital & Emory University.
Papers
More filters
Journal ArticleDOI
Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial
Raul G. Nogueira,Helmi L. Lutsep,Rishi Gupta,Tudor G Jovin,Gregory W. Albers,Gary Walker,David S Liebeskind,Wade S. Smith +7 more
TL;DR: Patients who have had large vessel occlusion strokes but are ineligible for (or refractory to) intravenous tissue plasminogen activator should be treated with the Trevo Retriever in preference to the Merci retriever.
Journal ArticleDOI
First Pass Effect: A New Measure for Stroke Thrombectomy Devices.
Osama O. Zaidat,Alicia C. Castonguay,Italo Linfante,Rishi Gupta,C Martin,William E. Holloway,Nils Mueller-Kronast,Joey English,Guilherme Dabus,Tim W. Malisch,Franklin A. Marden,Hormozd Bozorgchami,Andrew R. Xavier,Ansaar T Rai,Michael T. Froehler,Aamir Badruddin,Thanh N. Nguyen,M. Asif Taqi,Michael G. Abraham,Albert J. Yoo,Vallabh Janardhan,Hashem Shaltoni,Roberta Novakovic,Alex Abou-Chebl,Peng R. Chen,Gavin W. Britz,Chung Huan J Sun,Vibhav Bansal,Ritesh Kaushal,Ashish Nanda,Raul G. Nogueira +30 more
TL;DR: The achievement of complete revascularization from a single Solitaire thrombectomy device pass (FPE) is associated with significantly higher rates of good clinical outcome and the FPE is more frequently associated with the use of balloon guide catheters and less likely to be achieved with internal carotid artery terminus occlusion.
Journal ArticleDOI
Effect of a Balloon-Expandable Intracranial Stent vs Medical Therapy on Risk of Stroke in Patients With Symptomatic Intracranial Stenosis The VISSIT Randomized Clinical Trial
Osama O. Zaidat,Brian-Fred Fitzsimmons,Britton Keith Woodward,Zhigang Wang,Monika Killer-Oberpfalzer,Ajay K. Wakhloo,Rishi Gupta,Howard S. Kirshner,J. Thomas Megerian,James Lesko,Pamela Pitzer,Jandira Ramos,Alicia C. Castonguay,Stanley L. Barnwell,Wade S. Smith,Daryl R. Gress +15 more
TL;DR: Among patients with symptomatic intracranial arterial stenosis, the use of a balloon-expandable stent compared with medical therapy resulted in an increased 12-month risk of added stroke or TIA, while the EuroQol-5D showed no difference in any of the 5 dimensions between groups at 12- month follow-up.
Journal ArticleDOI
Fibromuscular Dysplasia: State of the Science and Critical Unanswered Questions A Scientific Statement From the American Heart Association
Jeffrey W. Olin,Heather L. Gornik,J. Michael Bacharach,José Biller,Lawrence J. Fine,Bruce H. Gray,William A. Gray,Rishi Gupta,Naomi M. Hamburg,Barry T. Katzen,Robert A. Lookstein,Alan B. Lumsden,Jane W. Newburger,Tatjana Rundek,C. John Sperati,James C. Stanley +15 more
TL;DR: A delay in diagnosis of fibromuscular dysplasia can lead to impaired quality of life and poor outcomes such as poorly controlled hypertension and its sequelae, TIA, stroke, dissection, or aneurysm rupture.
Journal ArticleDOI
Hemicraniectomy for Massive Middle Cerebral Artery Territory Infarction: A Systematic Review
TL;DR: Age may be a crucial factor in predicting functional outcome after hemicraniectomy in patients with large middle cerebral artery territory infarction.